John Zuris

Company: Editas Medicine

Job title: Director, Editing Technologies

Seminars:

Panel Discussion: Deliberating Current Gene Editing Techniques & Methods to Overcome Off- Target Genome Editing to Advance Its Clinical Ability 9:30 am

Which gene editing technique holds the most potential? How can we overcome off-target genome editing? Engaging regulatory authorities in discussions to advance its utilisationRead more

day: Conference Day 2